多肽合成;3x flag peptide;mdykdhdgdykdhdidykddddk;现货楚肽 ¥ 1200.00 获取底价 上海楚肽生物科技有限公司 商品描述 价格说明 联系我们 获取底价 商品描述 价格说明 联系我们 产品名称 psma-617;vipivotide tetraxetan;前列腺特异性膜抗原抑制剂 产品等级 优级品 产品规格 mg-g 产品类型 多肽 储存条件 低温 ...
上海楚肽生物科技有限公司 3年 OEM真实性核验 主营商品:多肽合、抗病毒肽、胸腺曲南、定制合成、标签多肽、酶荧光底物、磷酸化多肽、自组装多肽、免疫缺损病毒、钙蛋白酶抑制剂、多肽合成、荧光修饰、环肽、长肽合成、短肽、双环肽 进入店铺 全部商品
[177Lu]-PSMA-617 radionu- clide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study. Lancet Oncol 2018;19:825-33.Hofman MS, Violet J, Hicks RJ, Ferdinandus J, Ping Thang S, Akhurst T, et al. [(177)...
The KD values obtained for 44Sc-PSMA-617 and 177Lu-PSMA-617 were in the same range, but somewhat higher values were determined for the 68Ga-labeled PSMA ligands (Additional file 1: Figure S2). The results were converted into relative PSMA-binding affinities, which were similar for 44Sc-...
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30. Article Google Scholar Center MM, Jemal A, Lortet-Tieulent J, Ward E, Ferlay J, Brawley O, et al. International variation in prostate cancer incidence and mortality rates. Eur Urol. 2012;...
Re: [177Lu]-PSMA-617 Radionuclide Treatment in Patients with Metastatic Castration-resistant Prostate Cancer (LuPSMA Trial): A Single-centre, Single-arm, Phase 2 Study.doi:10.1016/j.eururo.2018.11.005Kathia De ManPiet OstEur Urol
CTN, JB, KD, NM, CNN, JW acquired data and revised manuscript. FG, CH, BB interpreted data and substantively revised manuscript. NT, SB, PM, FKHC substantively revised manuscript and approved of its final content. All authors read and approved the final manuscript. Corresponding author ...